163 related articles for article (PubMed ID: 34545573)
21. MYH9 and APOL1 are both associated with sickle cell disease nephropathy.
Ashley-Koch AE; Okocha EC; Garrett ME; Soldano K; De Castro LM; Jonassaint JC; Orringer EP; Eckman JR; Telen MJ
Br J Haematol; 2011 Nov; 155(3):386-94. PubMed ID: 21910715
[TBL] [Abstract][Full Text] [Related]
22. Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.
Bean CJ; Boulet SL; Ellingsen D; Pyle ME; Barron-Casella EA; Casella JF; Payne AB; Driggers J; Trau HA; Yang G; Jones K; Ofori-Acquah SF; Hooper WC; DeBaun MR
Blood; 2012 Nov; 120(18):3822-8. PubMed ID: 22966170
[TBL] [Abstract][Full Text] [Related]
23. Urinary Transforming Growth Factor β-1 as a Marker of Renal Dysfunction in Sickle Cell Disease.
Ghobrial EE; Abdel-Aziz HA; Kaddah AM; Mubarak NA
Pediatr Neonatol; 2016 Jun; 57(3):174-80. PubMed ID: 26508723
[TBL] [Abstract][Full Text] [Related]
24. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease.
Vasavda N; Menzel S; Kondaveeti S; Maytham E; Awogbade M; Bannister S; Cunningham J; Eichholz A; Daniel Y; Okpala I; Fulford T; Thein SL
Br J Haematol; 2007 Jul; 138(2):263-70. PubMed ID: 17593033
[TBL] [Abstract][Full Text] [Related]
25. Association of Genetic Polymorphisms of TGF-β1, HMOX1, and APOL1 With CKD in Nigerian Patients With and Without HIV.
Ekrikpo UE; Mnika K; Effa EE; Ajayi SO; Okwuonu C; Waziri B; Bello A; Dandara C; Kengne AP; Wonkam A; Okpechi I
Am J Kidney Dis; 2020 Jul; 76(1):100-108. PubMed ID: 32354559
[TBL] [Abstract][Full Text] [Related]
26. Nephrin as a biomarker of sickle cell glomerulopathy in Malawi.
Heimlich JB; Chipoka G; Elsherif L; David E; Ellis G; Kamthunzi P; Krysiak R; Mafunga P; Zhou Q; Cai J; Gopal S; Key NS; Ataga KI
Pediatr Blood Cancer; 2018 Jun; 65(6):e26993. PubMed ID: 29411937
[TBL] [Abstract][Full Text] [Related]
27. Characterization of kidney complications in patients with sickle cell anemia.
Isaza-López MC; Rojas-Rosas LF; Echavarría-Ospina L; Serna-Higuita LM
Rev Chil Pediatr; 2020 Feb; 91(1):51-57. PubMed ID: 32730413
[TBL] [Abstract][Full Text] [Related]
28. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature.
Haymann JP; Stankovic K; Levy P; Avellino V; Tharaux PL; Letavernier E; Grateau G; Baud L; Girot R; Lionnet F
Clin J Am Soc Nephrol; 2010 May; 5(5):756-61. PubMed ID: 20185605
[TBL] [Abstract][Full Text] [Related]
29. Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry.
Reidy KJ; Hjorten R; Parekh RS
Curr Opin Pediatr; 2018 Apr; 30(2):252-259. PubMed ID: 29406442
[TBL] [Abstract][Full Text] [Related]
30. Genetic Testing for
Kopp JB; Winkler CA
Clin J Am Soc Nephrol; 2020 Jan; 15(1):126-128. PubMed ID: 31740572
[No Abstract] [Full Text] [Related]
31. Microalbuminuria risks and glomerular filtration in children with sickle cell anaemia in Nigeria.
Ocheke IE; Mohamed S; Okpe ES; Bode-Thomas F; McCullouch MI
Ital J Pediatr; 2019 Nov; 45(1):143. PubMed ID: 31718702
[TBL] [Abstract][Full Text] [Related]
32. Renal disease in adult Nigerians with sickle cell anemia: a report of prevalence, clinical features and risk factors.
Bolarinwa RA; Akinlade KS; Kuti MA; Olawale OO; Akinola NO
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):171-5. PubMed ID: 22237246
[TBL] [Abstract][Full Text] [Related]
33. In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.
Anderson BR; Howell DN; Soldano K; Garrett ME; Katsanis N; Telen MJ; Davis EE; Ashley-Koch AE
PLoS Genet; 2015 Jul; 11(7):e1005349. PubMed ID: 26147622
[TBL] [Abstract][Full Text] [Related]
34. Congolese children with sickle cell trait may exhibit glomerular hyperfiltration: A case control study.
Aloni MN; Ngiyulu RM; Nsibu CN; Ekulu PM; Makulo JR; Gini-Ehungu JL; Nseka NM; Lepira FB
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 28102613
[TBL] [Abstract][Full Text] [Related]
35. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.
Matsha TE; Kengne AP; Masconi KL; Yako YY; Erasmus RT
BMC Genet; 2015 Jun; 16():69. PubMed ID: 26112018
[TBL] [Abstract][Full Text] [Related]
36. [Screening for nephropathy in major sickle cell syndromes in patients monitored at the National Reference Center for Sickle Cell Disease in Niamey, Niger].
Garba M; Moussa Tondi ZM; Diongoule H; Aboubacar S; Ide A; Biyao-Nelson NR; Soumaila I; Alido S
Nephrol Ther; 2018 Nov; 14(6):462-466. PubMed ID: 29311011
[TBL] [Abstract][Full Text] [Related]
37. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
38. Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease.
Bergmann S; Zheng D; Barredo J; Abboud MR; Jaffa AA
J Pediatr Hematol Oncol; 2006 Mar; 28(3):147-53. PubMed ID: 16679937
[TBL] [Abstract][Full Text] [Related]
39. Biomarkers of sickle cell nephropathy in Senegal.
Ndour EHM; Mnika K; Tall FG; Seck M; Ly ID; Nembaware V; Mazandu GK; Sagna Bassène HAT; Dione R; Ndongo AA; Diop JPD; Barry NOK; Djité M; Ndiaye Diallo R; Guèye PM; Diop S; Diagne I; Cissé A; Wonkam A; Lopez Sall P
PLoS One; 2022; 17(11):e0273745. PubMed ID: 36409722
[TBL] [Abstract][Full Text] [Related]
40.
Young BA; Wilson JG; Reiner A; Kestenbaum B; Franceschini N; Bansal N; Correa A; Himmelfarb J; Katz R
Kidney Med; 2021; 3(6):962-973.e1. PubMed ID: 34939005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
